Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Will gold be Paulson's next "Greatest Trade Ever?"

When famed hedge-fund manager John Paulson speaks, people listen. And it's no wonder. Paulson made his way into the financial history books thanks to what many now call the "greatest trade ever." Paulson & Co. shorted the subprime mortgage market before the collapse ba...
Peter Krauth | October 28, 2012 |

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. Biopharmaceutical firm Retrophin Inc. (RTRX:NASDAQ) shares are trading much lower today as the co...
Streetwise Reports | August 26, 2019 |

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...
Streetwise Reports | September 25, 2019 |

Oil Reverses Lower Faster Than You Can Blink

Although oil bulls managed to push the futures higher and broke above the upper border of the rising green trend channel during yesterday’s session, Monday’s upswing turned out only temporary. Earlier today, crude oil futures opened t...
Nadia Simmons | January 2, 2020 |

Biopharma Shows 'Good Start to 2020 News Flow'

The two developments that already took place this year are addressed in an H.C. Wainwright & Co. report. In a Jan. 16 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Ligand Pharmaceuticals Inc. (LGND:NASDAQ) kicked off the year with news ...
Streetwise Reports | January 22, 2020 |

Banks Island (V.BOZ) poised for gold production in B.C.

Q&A interview with Banks Island Gold Ltd. President, Director and CEO, Benjamin Mossman We are here today with Ben Mossman, President & CEO of Banks Island Gold ( TSX: V.BOZ , Stock Forum ) who recently drilled 6.3 gpt Au over 52.5 meters at Red Mountain Gold Property. ...
Stockhouse Editorial | September 4, 2013 |

The S&P 500 Bears Are Getting Started

In yesterday’s flagship Stock Trading Alert, we have evaluated the week just over, and examined the health of the S&P 500 advance. As the S&P 500 declined profoundly yesterday, we’ll revisit the credit markets and one key S&P 500 sector to asses...
Monica Kingsley | April 22, 2020 |

Central Bank Hypnosis

One look at the chart of the U.S. financial markets against the backdrop of economic paralysis and suffering, and one is immediately filled with a myriad of emotions. Sympathy for those that have been afflicted by the most recent pandemic; fear for the families whose prim...
Streetwise Reports | June 2, 2020 |

Buzz on the Bullboards: A Comeback for Travel Stocks?

(Image via @AirCanada on Twitter.) This is the first trading week since the new US President and Vice President-elects were declared, bringing some stability to North American markets. Dow futures rallied this week on news that a major US drug company&CloseCurlyQuot...
Stockhouse Editorial | November 10, 2020 |

Disruptive. Transformative. Empowering. Integrated Digital Care for the Future.

CareSpan Health Inc. ( TSX-V.CSPN , Forum ) is a disruptive, transformative, and empowering company providing a digital healthcare platform that integrates digital care tools, capabilities, and data in one place. The company's proprietary "Clinic-in-the Cloud" is a c...
Dave Jackson | January 24, 2022 |
1 2